Atlas Trials

Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success

Clinical trial NCT05702879 · UNKNOWN

Trial details

NCT number
NCT05702879
Sponsor
Insel Gruppe AG, University Hospital Bern
Status
UNKNOWN
Study type
OBSERVATIONAL
Ulcerative Colitis
Start date
2023-09-06
Primary completion
2025-01-31
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.